Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents

J Antimicrob Chemother. 2003 Aug;52(2):294-6. doi: 10.1093/jac/dkg363. Epub 2003 Jul 15.

Abstract

Objectives: To determine the susceptibility of southern African strains of Yersinia pestis to novel as well as conventional antimicrobial agents.

Materials and methods: The MICs of 28 strains of Yersinia pestis from a southern African plague focus were determined by agar dilution.

Results: The most active agents were cefditoren and the fluoroquinolones, both conventional and novel. The in vitro activity of macrolides was poor against this member of the Enterobacteriaceae.

Conclusion: Further investigation of the novel quinolones olamufloxacin (HSR 903) and ABT 492 in animal models of plague would seem to be justified.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Bacterial / physiology*
  • Humans
  • Yersinia pestis / drug effects*
  • Yersinia pestis / isolation & purification

Substances

  • Anti-Bacterial Agents